Pathstone Family Office’s National Vision EYE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-32,102
Closed -$1.16M 1313
2022
Q4
$1.16M Buy
32,102
+3,315
+12% +$124K 0.01% 723
2022
Q3
$940K Buy
28,787
+16,715
+138% +$543K 0.01% 772
2022
Q2
$332K Buy
12,072
+103
+0.9% +$3.39K 0.01% 748
2022
Q1
$521K Sell
11,969
-10
-0.1% -$406 0.01% 531
2021
Q4
$575K Sell
11,979
-44
-0.4% -$2.36K 0.01% 504
2021
Q3
$683K Buy
12,023
+940
+8% +$51.9K 0.02% 405
2021
Q2
$567K Buy
11,083
+3,229
+41% +$158K 0.02% 420
2021
Q1
$344K Buy
+7,854
New +$374K 0.01% 442

Other funds holding EYE

Pathstone Family Office's EYE Position: Q1 2023 in Review

Pathstone Family Office sold out of National Vision (EYE) in Q1 2023, closing a stake of 32,102 shares — an estimated $1.16M sold.

Pathstone Family Office first reported a position in EYE in Q1 2021 and held it in 8 quarters. The position peaked at $1.16M in Q4 2022. 182 funds tracked by Wall St. Rank hold EYE as of Q1 2023.

  • Pathstone Family Office reported no remaining National Vision position as of Q1 2023 after selling out during the quarter.
  • Pathstone Family Office sold 32,102 National Vision shares in Q1 2023, an estimated $1.16M.
  • Pathstone Family Office first reported a position in National Vision in Q1 2021 and held it in 8 quarters.
  • Pathstone Family Office's National Vision position peaked at $1.16M in Q4 2022.
  • 182 funds tracked by Wall St. Rank held National Vision as of Q1 2023.

Based on Pathstone Family Office's 13F filing for Q1 2023, filed 15 May 2023.